ArticleAlimentary pharmacology & therapeutics2022

Letter: treatment with subcutaneous CT-P13 in Crohn's disease patients with intravenous infliximab failure.

Bénédicte Caron et al.PubMed ↗Publisher ↗

No numbers read from the abstract.